Berotralstat (BCX7353) is an orally active plasma kallikrein inhibitor. Berotralstat can reduce brain edema and is being studied for glioblastoma and hereditary angioedema[1][2].
Molecular Weight:
562.56
Purity:
99.70
CAS Number:
[1809010-50-1]
Formula:
C30H26F4N6O
Target:
Kallikrein
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
